136 related articles for article (PubMed ID: 20007106)
21. Chronic myeloid leukemia stem cell biology.
Crews LA; Jamieson CH
Curr Hematol Malig Rep; 2012 Jun; 7(2):125-32. PubMed ID: 22467334
[TBL] [Abstract][Full Text] [Related]
22. Preservation of Quiescent Chronic Myelogenous Leukemia Stem Cells by the Bone Marrow Microenvironment.
Shah M; Bhatia R
Adv Exp Med Biol; 2018; 1100():97-110. PubMed ID: 30411262
[TBL] [Abstract][Full Text] [Related]
23. Signaling pathways in chronic myeloid leukemia and leukemic stem cell maintenance: key role of stromal microenvironment.
Seke Etet PF; Vecchio L; Nwabo Kamdje AH
Cell Signal; 2012 Sep; 24(9):1883-8. PubMed ID: 22659137
[TBL] [Abstract][Full Text] [Related]
24. Leukemia stem cells: the root of chronic myeloid leukemia.
Zhou H; Xu R
Protein Cell; 2015 Jun; 6(6):403-12. PubMed ID: 25749979
[TBL] [Abstract][Full Text] [Related]
25. [Chronic myeloid leukemia stem cells: cross-talk with the niche].
Chomel JC; Aggoune D; Sorel N; Turhan AG
Med Sci (Paris); 2014 Apr; 30(4):452-61. PubMed ID: 24801043
[TBL] [Abstract][Full Text] [Related]
26. Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generation.
Abrahamsson AE; Geron I; Gotlib J; Dao KH; Barroga CF; Newton IG; Giles FJ; Durocher J; Creusot RS; Karimi M; Jones C; Zehnder JL; Keating A; Negrin RS; Weissman IL; Jamieson CH
Proc Natl Acad Sci U S A; 2009 Mar; 106(10):3925-9. PubMed ID: 19237556
[TBL] [Abstract][Full Text] [Related]
27. Preferential induction of apoptosis for primary human leukemic stem cells.
Guzman ML; Swiderski CF; Howard DS; Grimes BA; Rossi RM; Szilvassy SJ; Jordan CT
Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16220-5. PubMed ID: 12451177
[TBL] [Abstract][Full Text] [Related]
28. Leukemia stem cells.
Lane SW; Gilliland DG
Semin Cancer Biol; 2010 Apr; 20(2):71-6. PubMed ID: 20026405
[TBL] [Abstract][Full Text] [Related]
29. Osteoblast ablation reduces normal long-term hematopoietic stem cell self-renewal but accelerates leukemia development.
Bowers M; Zhang B; Ho Y; Agarwal P; Chen CC; Bhatia R
Blood; 2015 Apr; 125(17):2678-88. PubMed ID: 25742698
[TBL] [Abstract][Full Text] [Related]
30. GLI2 inhibition abrogates human leukemia stem cell dormancy.
Sadarangani A; Pineda G; Lennon KM; Chun HJ; Shih A; Schairer AE; Court AC; Goff DJ; Prashad SL; Geron I; Wall R; McPherson JD; Moore RA; Pu M; Bao L; Jackson-Fisher A; Munchhof M; VanArsdale T; Reya T; Morris SR; Minden MD; Messer K; Mikkola HK; Marra MA; Hudson TJ; Jamieson CH
J Transl Med; 2015 Mar; 13():98. PubMed ID: 25889765
[TBL] [Abstract][Full Text] [Related]
31. Biophysical differences between chronic myelogenous leukemic quiescent and proliferating stem/progenitor cells.
Guz NV; Patel SJ; Dokukin ME; Clarkson B; Sokolov I
Nanomedicine; 2016 Nov; 12(8):2429-2437. PubMed ID: 27431055
[TBL] [Abstract][Full Text] [Related]
32. A Deeply Quiescent Subset of CML LSC depend on FAO yet Avoid Deleterious ROS by Suppressing Mitochondrial Complex I.
Chimge NO; Chen MH; Nguyen C; Zhao Y; Wu X; Gonzalez PG; Ogana H; Hurwitz S; Teo JL; Chen X; Du J; Jin V; Kim YM; Ono M; Argüello RJ; Kahn M
Curr Mol Pharmacol; 2024; 17(1):e060923220758. PubMed ID: 37691195
[TBL] [Abstract][Full Text] [Related]
33. Identifying leukemia stem cells--is it feasible and does it matter?
Lutz C; Hoang VT; Buss E; Ho AD
Cancer Lett; 2013 Sep; 338(1):10-4. PubMed ID: 22820159
[TBL] [Abstract][Full Text] [Related]
34. Considerations for targeting malignant stem cells in leukemia.
Guzman ML; Jordan CT
Cancer Control; 2004; 11(2):97-104. PubMed ID: 15024346
[TBL] [Abstract][Full Text] [Related]
35. Investigating human leukemogenesis: from cell lines to in vivo models of human leukemia.
Kennedy JA; Barabé F
Leukemia; 2008 Nov; 22(11):2029-40. PubMed ID: 18685615
[TBL] [Abstract][Full Text] [Related]
36. Targeting tetramer-forming GABPβ isoforms impairs self-renewal of hematopoietic and leukemic stem cells.
Yu S; Jing X; Colgan JD; Zhao DM; Xue HH
Cell Stem Cell; 2012 Aug; 11(2):207-19. PubMed ID: 22862946
[TBL] [Abstract][Full Text] [Related]
37. Targeting of leukemia-initiating cells to develop curative drug therapies: straightforward but nontrivial concept.
Valent P
Curr Cancer Drug Targets; 2011 Jan; 11(1):56-71. PubMed ID: 21062243
[TBL] [Abstract][Full Text] [Related]
38. [Properties of leukemic stem cells and treatment strategy for the cure of chronic myelogenous leukemia].
Minami Y
Rinsho Ketsueki; 2013 Jun; 54(6):552-8. PubMed ID: 23823094
[No Abstract] [Full Text] [Related]
39. The versatility of haematopoietic stem cells: implications for leukaemia.
Brown G; Hughes PJ; Michell RH; Ceredig R
Crit Rev Clin Lab Sci; 2010 Aug; 47(4):171-80. PubMed ID: 21182396
[TBL] [Abstract][Full Text] [Related]
40. Influence of Bone Marrow Microenvironment on Leukemic Stem Cells: Breaking Up an Intimate Relationship.
Agarwal P; Bhatia R
Adv Cancer Res; 2015; 127():227-52. PubMed ID: 26093902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
